Literature DB >> 33510582

Factors Related to Bone Metabolism in Kidney Transplant Recipients.

Chenxiu Wang1, Yanan Huo1, Xinchang Li2, Anhua Lin1, Qingxiang Hu2, Changhui Xiong3, Ying Deng1.   

Abstract

This study is aimed at establishing the prevalence of osteoporosis and osteopenia in kidney transplant recipients (KTRs) and determining the risk factors for bone mass loss. We invited KTRs who were under regular follow-up at Jiangxi Provincial People's Hospital Affiliated with Nanchang University to attend an assessment of osteoporotic risk assessed by questionnaire, biochemical profile, and dual-energy X-ray absorptiometry (DXA) scanning of the lumbar spine, total hip, and femoral neck. Binary logistic regression models were used to investigate the relationship between the different variables and bone mass density (BMD). A total of 216 patients satisfied the inclusion criteria. The group consisted of 156 men (72.22%) and 60 women (27.78%), and the mean age was 41.50 ± 9.98 years. There were 81 patients with normal bone mass (37.50%) and 135 patients with bone mass loss (62.50%). Logistic regression analysis showed that a higher phosphorus value and higher alkaline phosphatase concentration and a longer use of glucocorticoids were risk factors for bone mass loss in KTRs, and maintaining an appropriate weight and exercising an appropriate number of times per week helped to maintain bone mass.
Copyright © 2021 Chenxiu Wang et al.

Entities:  

Year:  2021        PMID: 33510582      PMCID: PMC7826208          DOI: 10.1155/2021/6679095

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  21 in total

1.  Executive Summary: Clinical Practice Guideline of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) in China.

Authors:  Zhi-Hong Liu; Guisen Li; Ling Zhang; Jianghua Chen; Xiaonong Chen; Jinghong Zhao; Xinling Liang
Journal:  Kidney Dis (Basel)       Date:  2019-07-09

Review 2.  Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton.

Authors:  S Epstein
Journal:  J Bone Miner Res       Date:  1996-01       Impact factor: 6.741

3.  Development of lumbar bone mineral density in the late course after kidney transplantation.

Authors:  Vincent M Brandenburg; Markus Ketteler; Walter J Fassbender; Nicole Heussen; Thomas Freuding; Juergen Floege; Thomas H Ittel
Journal:  Am J Kidney Dis       Date:  2002-11       Impact factor: 8.860

4.  KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2017-06-21

5.  Risk of hip fracture among dialysis and renal transplant recipients.

Authors:  Adrianne M Ball; Daniel L Gillen; Donald Sherrard; Noel S Weiss; Scott S Emerson; Steve L Seliger; Bryan R Kestenbaum; Catherine Stehman-Breen
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density.

Authors:  C K T Farmer; G Hampson; I C Abbs; R M Hilton; C G Koffman; I Fogelman; S H Sacks
Journal:  Am J Transplant       Date:  2006-12       Impact factor: 8.086

7.  Long-term fracture risk following renal transplantation: a population-based study.

Authors:  Line M Vautour; L Joseph Melton; Bart L Clarke; Sara J Achenbach; Ann L Oberg; James T McCarthy
Journal:  Osteoporos Int       Date:  2003-12-09       Impact factor: 4.507

Review 8.  Fracture risk in kidney transplant recipients: a systematic review.

Authors:  Kyla L Naylor; Alvin H Li; Ngan N Lam; Anthony B Hodsman; Sophie A Jamal; Amit X Garg
Journal:  Transplantation       Date:  2013-06-27       Impact factor: 4.939

Review 9.  Bone disease after renal transplantation.

Authors:  Hartmut H Malluche; Marie-Claude Monier-Faugere; Johann Herberth
Journal:  Nat Rev Nephrol       Date:  2009-11-17       Impact factor: 28.314

10.  Immunosuppressants in Organ Transplantation.

Authors:  Burkhard Tönshoff
Journal:  Handb Exp Pharmacol       Date:  2019-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.